Open-mkt buys · 90d
—
0 trades · 0 insiders
Open-mkt sales · 90d
—
0 trades · 0 insiders
Net · 90d
$0
Insiders on file
32
Daily buy vs sell · 90 days
No data yet.
Insiders
| Insider | Role | Trades | Bought | Sold | Last trade |
|---|---|---|---|---|---|
| Yeganeh Reuven | Director, 10% Owner | 15 | $0 | $33.32M | 2026-03-17 |
| Deerfield Mgmt HIF, L.P. | Director, 10% Owner | 12 | $0 | $0 | 2025-04-21 |
| Merril Gregory Louis | Director | 2 | $0 | $0 | 2025-04-14 |
| Moses Alan Charles | Director | 9 | $20.0K | $0 | 2025-04-14 |
| Wolfson Marina | SVP of Finance & Operations | 19 | $15.0K | $0 | 2025-04-14 |
| Bassan Merav | Chief Development Officer | 16 | $0 | $0 | 2025-04-14 |
| Solomon Jonathan Eitan | Chief Executive Officer | 25 | $100.0K | $0 | 2025-04-14 |
| Blum Susan | Director | 3 | $0 | $0 | 2025-04-14 |
| Greig Russell | Director | 9 | $15.0K | $0 | 2025-04-14 |
| GOODMAN JESSE | Director | 3 | $0 | $0 | 2025-04-14 |
| Williams Eddie | Director | 4 | $0 | $0 | 2025-04-14 |
| LEFF JONATHAN S | Director | 3 | $0 | $0 | 2025-04-14 |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | Director | 7 | $0 | $0 | 2025-04-14 |
| Oron Assaf | Chief Business Officer | 21 | $3.0K | $4.1K | 2024-09-16 |
| Flynn James E | Director | 1 | $0 | $0 | 2024-07-11 |
| Deerfield Healthcare Innovations Fund II, L.P. | Director, 10% Owner | 4 | $0 | $0 | 2024-07-09 |
| Cystic Fibrosis Foundation | 10% Owner | 2 | $0 | $0 | 2024-05-15 |
| GORDON CARL L | 10% Owner | 3 | $0 | $9.3K | 2024-05-15 |
| Chimovits Erez | Director, 10% Owner | 10 | $199.2K | $0 | 2024-03-15 |
| Dambach Michael E. | Director | 1 | $0 | $0 | 2023-08-21 |
| Marks Jason M. | Director | 1 | $0 | $0 | 2023-08-21 |
| Sullivan Lynne Marie | Director | 6 | $50.0K | $0 | 2023-03-01 |
| OrbiMed Israel GP Ltd. | Director, 10% Owner | 7 | $208.3K | $0 | 2023-02-27 |
| Ugwumba Chidozie | Other | 62 | $0 | $318.9K | 2022-11-04 |
| Amusa Gbolahan | Director | 8 | $0 | $0 | 2022-03-29 |
| GROSSMAN JONAS | Director, 10% Owner | 18 | $79.3K | $0 | 2022-03-29 |
| Walton Thomas Layton | 10% Owner | 2 | $0 | $0 | 2021-12-31 |
| OrbiMed Israel BioFund GP Limited Partnership | Director, 10% Owner | 4 | $77.9K | $0 | 2021-07-28 |
| SEKHRI PAUL J | Director | 4 | $50.0K | $0 | 2021-07-28 |
| Puttagunta Sailaja | Chief Medical Officer | 2 | $0 | $0 | 2021-03-30 |
| Mountain Wood LLC | 10% Owner | 6 | $0 | $0 | 2020-07-13 |
| Breski Yaron | Director | 1 | $0 | $0 | 2020-03-25 |
Trade history
| Insider | Role | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|---|
| Yeganeh Reuven | Director, 10% Owner | C Conversion deriv | 2026-03-17 | 2026-03-18 | 1,060 | — | $0 | 0 | SEC↗ |
| Yeganeh Reuven | Director, 10% Owner | S Sale | 2026-03-17 | 2026-03-18 | 530,000 | $5.00 | $2.65M | 0 | SEC↗ |
| Yeganeh Reuven | Director, 10% Owner | C Conversion | 2026-03-17 | 2026-03-18 | 530,000 | $2.00 | $1.06M | 530,000 | SEC↗ |
| Yeganeh Reuven | Director, 10% Owner | S Sale deriv | 2026-03-16 | 2026-03-18 | 1,300,000 | $5.00 | $6.50M | 2,000,000 | SEC↗ |
| Yeganeh Reuven | Director, 10% Owner | S Sale deriv | 2026-03-16 | 2026-03-18 | 2,000,000 | $5.24 | $10.48M | 1,700,000 | SEC↗ |
| Yeganeh Reuven | Director, 10% Owner | C Conversion deriv | 2026-03-16 | 2026-03-18 | 900 | — | $0 | 1,060 | SEC↗ |
| Yeganeh Reuven | Director, 10% Owner | S Sale deriv | 2026-03-16 | 2026-03-18 | 1,700,000 | $4.76 | $8.09M | 0 | SEC↗ |
| Yeganeh Reuven | Director, 10% Owner | C Conversion | 2026-03-16 | 2026-03-18 | 450,000 | $2.00 | $900.0K | 450,000 | SEC↗ |
| Yeganeh Reuven | Director, 10% Owner | S Sale | 2026-03-16 | 2026-03-18 | 450,000 | $5.00 | $2.25M | 0 | SEC↗ |
| Yeganeh Reuven | Director, 10% Owner | C Conversion deriv | 2026-03-13 | 2026-03-13 | 740 | — | $0 | 1,960 | SEC↗ |
| Yeganeh Reuven | Director, 10% Owner | C Conversion | 2026-03-13 | 2026-03-13 | 370,000 | $2.00 | $740.0K | 370,000 | SEC↗ |
| Yeganeh Reuven | Director, 10% Owner | S Sale | 2026-03-13 | 2026-03-13 | 370,000 | $5.00 | $1.85M | 0 | SEC↗ |
| Yeganeh Reuven | Director, 10% Owner | C Conversion deriv | 2026-03-12 | 2026-03-13 | 600 | — | $0 | 2,700 | SEC↗ |
| Yeganeh Reuven | Director, 10% Owner | S Sale | 2026-03-12 | 2026-03-13 | 300,000 | $5.00 | $1.50M | 0 | SEC↗ |
| Yeganeh Reuven | Director, 10% Owner | C Conversion | 2026-03-11 | 2026-03-13 | 300,000 | $2.00 | $600.0K | 30,000 | SEC↗ |
| Deerfield Mgmt HIF, L.P. | Director | A Award deriv | 2025-04-21 | 2025-04-23 | 1,611,864 | — | $0 | 1,611,864 | SEC↗ |
| Deerfield Mgmt HIF, L.P. | Director | A Award deriv | 2025-04-21 | 2025-04-23 | 1,611,864 | — | $0 | 1,611,864 | SEC↗ |
| Blum Susan | Director | A Award deriv | 2025-04-14 | 2025-04-18 | 17,600 | — | $0 | 17,600 | SEC↗ |
| Solomon Jonathan Eitan | Chief Executive Officer | A Award deriv | 2025-04-14 | 2025-04-18 | 380,500 | — | $0 | 380,500 | SEC↗ |
| Moses Alan Charles | Director | A Award deriv | 2025-04-14 | 2025-04-18 | 17,600 | — | $0 | 17,600 | SEC↗ |
| Williams Eddie | Director | A Award deriv | 2025-04-14 | 2025-04-18 | 17,600 | — | $0 | 17,600 | SEC↗ |
| Bassan Merav | Chief Development Officer | A Award deriv | 2025-04-14 | 2025-04-18 | 95,000 | — | $0 | 95,000 | SEC↗ |
| GOODMAN JESSE | Director | A Award deriv | 2025-04-14 | 2025-04-18 | 17,600 | — | $0 | 17,600 | SEC↗ |
| LEFF JONATHAN S | Director | A Award deriv | 2025-04-14 | 2025-04-18 | 17,600 | — | $0 | 17,600 | SEC↗ |
| Greig Russell | Director | A Award deriv | 2025-04-14 | 2025-04-18 | 35,200 | — | $0 | 35,200 | SEC↗ |
| Wolfson Marina | Chief Financial Officer | A Award deriv | 2025-04-14 | 2025-04-18 | 95,000 | — | $0 | 95,000 | SEC↗ |
| DEERFIELD MANAGEMENT COMPANY, | Director | A Award deriv | 2025-04-14 | 2025-04-18 | 17,600 | — | $0 | 17,600 | SEC↗ |
| Wolfson Marina | Chief Financial Officer | A Award deriv | 2025-04-14 | 2025-04-21 | 95,000 | — | $0 | 95,000 | SEC↗ |
| Greig Russell | Director | A Award deriv | 2025-04-14 | 2025-04-21 | 35,200 | — | $0 | 35,200 | SEC↗ |
| Blum Susan | Director | A Award deriv | 2025-04-14 | 2025-04-21 | 17,600 | — | $0 | 17,600 | SEC↗ |
| LEFF JONATHAN S | Director | A Award deriv | 2025-04-14 | 2025-04-21 | 17,600 | — | $0 | 17,600 | SEC↗ |
| Moses Alan Charles | Director | A Award deriv | 2025-04-14 | 2025-04-21 | 17,600 | — | $0 | 17,600 | SEC↗ |
| Williams Eddie | Director | A Award deriv | 2025-04-14 | 2025-04-21 | 17,600 | — | $0 | 17,600 | SEC↗ |
| GOODMAN JESSE | Director | A Award deriv | 2025-04-14 | 2025-04-21 | 17,600 | — | $0 | 17,600 | SEC↗ |
| Solomon Jonathan Eitan | Chief Executive Officer | A Award deriv | 2025-04-14 | 2025-04-21 | 380,500 | — | $0 | 380,500 | SEC↗ |
| Bassan Merav | Chief Development Officer | A Award deriv | 2025-04-14 | 2025-04-21 | 95,000 | — | $0 | 95,000 | SEC↗ |
| Merril Gregory Louis | Director | A Award deriv | 2025-04-14 | 2025-04-21 | 17,600 | — | $0 | 17,600 | SEC↗ |
| Solomon Jonathan Eitan | Chief Executive Officer | A Award | 2025-04-14 | 2025-04-18 | 126,748 | — | $0 | 126,748 | SEC↗ |
| Bassan Merav | Chief Development Officer | A Award | 2025-04-14 | 2025-04-18 | 79,597 | — | $0 | 79,597 | SEC↗ |
| Wolfson Marina | Chief Financial Officer | A Award | 2025-04-14 | 2025-04-18 | 68,545 | — | $0 | 68,545 | SEC↗ |
| Wolfson Marina | Chief Financial Officer | A Award | 2025-04-14 | 2025-04-21 | 68,545 | — | $0 | 68,545 | SEC↗ |
| Solomon Jonathan Eitan | Chief Executive Officer | A Award | 2025-04-14 | 2025-04-21 | 126,748 | — | $0 | 126,748 | SEC↗ |
| Bassan Merav | Chief Development Officer | A Award | 2025-04-14 | 2025-04-21 | 79,597 | — | $0 | 79,597 | SEC↗ |
| DEERFIELD MANAGEMENT COMPANY, | Director | A Award deriv | 2025-02-27 | 2025-03-03 | 1,258,614 | — | $0 | 1,258,614 | SEC↗ |
| DEERFIELD MANAGEMENT COMPANY, | Director | A Award deriv | 2025-02-27 | 2025-03-03 | 1,258,614 | — | $0 | 1,258,614 | SEC↗ |
| DEERFIELD MANAGEMENT COMPANY, | Director | M Exercise deriv | 2025-02-27 | 2025-03-03 | 1,611,863 | — | $0 | 405,637 | SEC↗ |
| DEERFIELD MANAGEMENT COMPANY, | Director | M Exercise deriv | 2025-02-27 | 2025-03-03 | 1,611,863 | — | $0 | 405,637 | SEC↗ |
| DEERFIELD MANAGEMENT COMPANY, | Director | M Exercise | 2025-02-27 | 2025-03-03 | 353,249 | $0.93 | $328.5K | 1,247,054 | SEC↗ |
| DEERFIELD MANAGEMENT COMPANY, | Director | M Exercise | 2025-02-27 | 2025-03-03 | 353,249 | $0.93 | $328.5K | 1,247,054 | SEC↗ |
| Oron Assaf | Chief Business Officer | A Award | 2024-09-16 | 2024-09-18 | 25,804 | — | $0 | 25,804 | SEC↗ |
| Solomon Jonathan Eitan | Chief Executive Officer | A Award | 2024-09-16 | 2024-09-18 | 50,556 | — | $0 | 53,056 | SEC↗ |
| Bassan Merav | Chief Development Officer | A Award | 2024-09-16 | 2024-09-18 | 31,749 | — | $0 | 31,749 | SEC↗ |
| Deerfield Mgmt HIF, L.P. | Director | M Exercise deriv | 2024-07-15 | 2024-07-17 | 5,883 | — | $0 | 47,957 | SEC↗ |
| Deerfield Mgmt HIF, L.P. | Director | M Exercise deriv | 2024-07-15 | 2024-07-17 | 5,883 | — | $0 | 47,957 | SEC↗ |
| Deerfield Mgmt HIF, L.P. | Director | M Exercise | 2024-07-15 | 2024-07-17 | 5,883,000 | — | $0 | 8,938,049 | SEC↗ |
| Deerfield Mgmt HIF, L.P. | Director | M Exercise | 2024-07-15 | 2024-07-17 | 5,883,000 | — | $0 | 8,938,049 | SEC↗ |
| Moses Alan Charles | Director | A Award deriv | 2024-07-11 | 2024-07-15 | 176,000 | — | $0 | 176,000 | SEC↗ |
| Oron Assaf | Chief Business Officer | A Award deriv | 2024-07-11 | 2024-07-15 | 237,500 | — | $0 | 237,500 | SEC↗ |
| Williams Eddie | Director | A Award deriv | 2024-07-11 | 2024-07-15 | 176,000 | — | $0 | 176,000 | SEC↗ |
| Merril Gregory Louis | Director | A Award deriv | 2024-07-11 | 2024-07-15 | 264,000 | — | $0 | 264,000 | SEC↗ |
| GOODMAN JESSE | Director | A Award deriv | 2024-07-11 | 2024-07-15 | 264,000 | — | $0 | 264,000 | SEC↗ |
| LEFF JONATHAN S | Director | A Award deriv | 2024-07-11 | 2024-07-15 | 264,000 | — | $0 | 264,000 | SEC↗ |
| Solomon Jonathan Eitan | Chief Executive Officer | A Award deriv | 2024-07-11 | 2024-07-15 | 3,805,000 | — | $0 | 3,805,000 | SEC↗ |
| Wolfson Marina | Chief Financial Officer | A Award deriv | 2024-07-11 | 2024-07-15 | 950,000 | — | $0 | 950,000 | SEC↗ |
| Bassan Merav | Chief Development Officer | A Award deriv | 2024-07-11 | 2024-07-15 | 950,000 | — | $0 | 950,000 | SEC↗ |
| Greig Russell | Director | A Award deriv | 2024-07-11 | 2024-07-15 | 352,000 | — | $0 | 352,000 | SEC↗ |
| Blum Susan | Director | A Award deriv | 2024-07-11 | 2024-07-15 | 264,000 | — | $0 | 264,000 | SEC↗ |
| Flynn James E | Director | A Award deriv | 2024-07-11 | 2024-07-15 | 264,000 | — | $0 | 264,000 | SEC↗ |
| Deerfield Healthcare Innovatio | Director, 10% Owner | A Award deriv | 2024-07-09 | 2024-07-11 | 20,175,000 | — | $0 | 20,175,000 | SEC↗ |
| Deerfield Healthcare Innovatio | Director, 10% Owner | A Award deriv | 2024-07-09 | 2024-07-11 | 20,175,000 | — | $0 | 20,175,000 | SEC↗ |
| Deerfield Healthcare Innovatio | Director, 10% Owner | A Award deriv | 2024-07-09 | 2024-07-11 | 722,175 | — | $0 | 722,175 | SEC↗ |
| Deerfield Healthcare Innovatio | Director, 10% Owner | A Award deriv | 2024-07-09 | 2024-07-11 | 722,175 | — | $0 | 722,175 | SEC↗ |
| Cystic Fibrosis Foundation | 10% Owner | X Exercise deriv | 2024-05-15 | 2024-05-17 | 4,778,265 | — | $0 | 0 | SEC↗ |
| GORDON CARL L | 10% Owner | X Exercise deriv | 2024-05-15 | 2024-05-20 | 9,280,408 | — | $0 | 0 | SEC↗ |
| Cystic Fibrosis Foundation | 10% Owner | X Exercise | 2024-05-15 | 2024-05-17 | 4,778,265 | — | $0 | 9,330,580 | SEC↗ |
| GORDON CARL L | 10% Owner | X Exercise | 2024-05-15 | 2024-05-20 | 9,280,408 | $0.24 | $2.23M | 13,797,997 | SEC↗ |
| GORDON CARL L | 10% Owner | S Sale | 2024-05-15 | 2024-05-20 | 24,344 | $0.38 | $9.3K | 13,773,653 | SEC↗ |
| Chimovits Erez | 10% Owner | P Buy deriv | 2024-03-15 | 2024-03-19 | 4,327 | — | $0 | 4,327 | SEC↗ |
| Chimovits Erez | 10% Owner | P Buy deriv | 2024-03-15 | 2024-03-19 | 2,163,500 | — | $0 | 2,163,500 | SEC↗ |
| Deerfield Mgmt HIF, L.P. | Director, 10% Owner | A Award deriv | 2024-03-15 | 2024-03-19 | 13,490 | — | $0 | 13,490 | SEC↗ |
| Deerfield Mgmt HIF, L.P. | Director, 10% Owner | A Award deriv | 2024-03-15 | 2024-03-19 | 40,350 | — | $0 | 53,840 | SEC↗ |
| Deerfield Mgmt HIF, L.P. | Director, 10% Owner | A Award deriv | 2024-03-15 | 2024-03-19 | 40,350 | — | $0 | 53,840 | SEC↗ |
| Deerfield Mgmt HIF, L.P. | Director, 10% Owner | A Award deriv | 2024-03-15 | 2024-03-19 | 13,490 | — | $0 | 13,490 | SEC↗ |
| Deerfield Mgmt HIF, L.P. | Director, 10% Owner | A Award | 2024-03-15 | 2024-03-19 | 3,055,049 | — | $0 | 3,055,049 | SEC↗ |
| Deerfield Mgmt HIF, L.P. | Director, 10% Owner | A Award | 2024-03-15 | 2024-03-19 | 3,055,049 | — | $0 | 3,055,049 | SEC↗ |
| Oron Assaf | Chief Business Officer | D To issuer deriv | 2023-12-11 | 2023-12-13 | 31,500 | — | $0 | 0 | SEC↗ |
| Oron Assaf | Chief Business Officer | A Award deriv | 2023-12-11 | 2023-12-13 | 8,290 | — | $0 | 8,290 | SEC↗ |
| Oron Assaf | Chief Business Officer | D To issuer deriv | 2023-12-11 | 2023-12-13 | 33,250 | — | $0 | 0 | SEC↗ |
| Oron Assaf | Chief Business Officer | A Award deriv | 2023-12-11 | 2023-12-13 | 8,750 | — | $0 | 8,750 | SEC↗ |
| Solomon Jonathan Eitan | Chief Executive Officer | D To issuer deriv | 2023-12-11 | 2023-12-13 | 205,000 | — | $0 | 0 | SEC↗ |
| Solomon Jonathan Eitan | Chief Executive Officer | A Award deriv | 2023-12-11 | 2023-12-13 | 40,000 | — | $0 | 40,000 | SEC↗ |
| Solomon Jonathan Eitan | Chief Executive Officer | D To issuer deriv | 2023-12-11 | 2023-12-13 | 152,000 | — | $0 | 0 | SEC↗ |
| Solomon Jonathan Eitan | Chief Executive Officer | A Award deriv | 2023-12-11 | 2023-12-13 | 37,895 | — | $0 | 37,895 | SEC↗ |
| Solomon Jonathan Eitan | Chief Executive Officer | D To issuer deriv | 2023-12-11 | 2023-12-13 | 144,000 | — | $0 | 0 | SEC↗ |
| Solomon Jonathan Eitan | Chief Executive Officer | A Award deriv | 2023-12-11 | 2023-12-13 | 146,429 | — | $0 | 146,429 | SEC↗ |
| Bassan Merav | Chief Development Officer | D To issuer deriv | 2023-12-11 | 2023-12-13 | 100,000 | — | $0 | 0 | SEC↗ |
| Bassan Merav | Chief Development Officer | A Award deriv | 2023-12-11 | 2023-12-13 | 12,500 | — | $0 | 12,500 | SEC↗ |
| Bassan Merav | Chief Development Officer | D To issuer deriv | 2023-12-11 | 2023-12-13 | 47,500 | — | $0 | 0 | SEC↗ |
| Bassan Merav | Chief Development Officer | A Award deriv | 2023-12-11 | 2023-12-13 | 71,429 | — | $0 | 71,429 | SEC↗ |
| Wolfson Marina | Chief Financial Officer | A Award deriv | 2023-12-11 | 2023-12-13 | 35,715 | — | $0 | 35,715 | SEC↗ |
| Wolfson Marina | Chief Financial Officer | D To issuer deriv | 2023-12-11 | 2023-12-13 | 36,000 | — | $0 | 0 | SEC↗ |
| Wolfson Marina | Chief Financial Officer | A Award deriv | 2023-12-11 | 2023-12-13 | 8,750 | — | $0 | 8,750 | SEC↗ |
| Wolfson Marina | Chief Financial Officer | D To issuer deriv | 2023-12-11 | 2023-12-13 | 33,250 | — | $0 | 0 | SEC↗ |
| Wolfson Marina | Chief Financial Officer | A Award deriv | 2023-12-11 | 2023-12-13 | 9,474 | — | $0 | 9,474 | SEC↗ |
| Wolfson Marina | Chief Financial Officer | D To issuer deriv | 2023-12-11 | 2023-12-13 | 50,000 | — | $0 | 0 | SEC↗ |
| Oron Assaf | Chief Business Officer | S Sale | 2023-11-29 | 2023-12-01 | 2,056 | $0.34 | $699 | 0 | SEC↗ |
| Oron Assaf | Chief Business Officer | S Sale | 2023-11-29 | 2023-12-01 | 3,414 | $0.35 | $1.2K | 2,056 | SEC↗ |
| Oron Assaf | Chief Business Officer | S Sale | 2023-11-29 | 2023-12-01 | 5,444 | $0.40 | $2.2K | 5,470 | SEC↗ |
| Oron Assaf | Chief Business Officer | D To issuer deriv | 2023-10-29 | 2023-10-31 | 155,363 | — | $0 | 0 | SEC↗ |
| Oron Assaf | Chief Business Officer | A Award deriv | 2023-10-29 | 2023-10-31 | 155,363 | — | $0 | 0 | SEC↗ |
| Oron Assaf | Chief Business Officer | D To issuer deriv | 2023-10-29 | 2023-10-31 | 82,667 | — | $0 | 0 | SEC↗ |
| Oron Assaf | Chief Business Officer | A Award deriv | 2023-10-29 | 2023-10-31 | 82,667 | — | $0 | 0 | SEC↗ |
| Oron Assaf | Chief Business Officer | D To issuer deriv | 2023-10-29 | 2023-10-31 | 46,966 | — | $0 | 0 | SEC↗ |
| Oron Assaf | Chief Business Officer | A Award deriv | 2023-10-29 | 2023-10-31 | 46,966 | — | $0 | 0 | SEC↗ |
| Solomon Jonathan Eitan | Chief Executive Officer | A Award deriv | 2023-10-29 | 2023-10-31 | 182,133 | — | $0 | 0 | SEC↗ |
| Solomon Jonathan Eitan | Chief Executive Officer | A Award deriv | 2023-10-29 | 2023-10-31 | 284,701 | — | $0 | 0 | SEC↗ |
| Solomon Jonathan Eitan | Chief Executive Officer | D To issuer deriv | 2023-10-29 | 2023-10-31 | 284,701 | — | $0 | 0 | SEC↗ |
| Solomon Jonathan Eitan | Chief Executive Officer | A Award deriv | 2023-10-29 | 2023-10-31 | 201,708 | — | $0 | 0 | SEC↗ |
| Solomon Jonathan Eitan | Chief Executive Officer | D To issuer deriv | 2023-10-29 | 2023-10-31 | 201,708 | — | $0 | 0 | SEC↗ |
| Solomon Jonathan Eitan | Chief Executive Officer | D To issuer deriv | 2023-10-29 | 2023-10-31 | 182,133 | — | $0 | 0 | SEC↗ |
| Wolfson Marina | Chief Financial Officer | A Award deriv | 2023-10-29 | 2023-10-31 | 59,800 | — | $0 | 59,800 | SEC↗ |
| Bassan Merav | Chief Development Officer | D To issuer deriv | 2023-10-29 | 2023-10-31 | 189,997 | — | $0 | 0 | SEC↗ |
| Bassan Merav | Chief Development Officer | A Award deriv | 2023-10-29 | 2023-10-31 | 189,997 | — | $0 | 0 | SEC↗ |
| Williams Eddie | Director | A Award deriv | 2023-10-19 | 2023-10-23 | 41,000 | — | $0 | 41,000 | SEC↗ |
| Dambach Michael E. | Director | A Award deriv | 2023-08-21 | 2023-08-23 | 41,000 | — | $0 | 41,000 | SEC↗ |
| Marks Jason M. | Director | A Award deriv | 2023-08-21 | 2023-08-23 | 41,000 | — | $0 | 41,000 | SEC↗ |
| Oron Assaf | Chief Business Officer | P Buy | 2023-05-22 | 2023-05-24 | 3,192 | $0.27 | $862 | 10,914 | SEC↗ |
| Oron Assaf | Chief Business Officer | P Buy | 2023-05-19 | 2023-05-22 | 6,521 | $0.28 | $1.8K | 7,722 | SEC↗ |
| Oron Assaf | Chief Business Officer | P Buy | 2023-05-18 | 2023-05-22 | 1,201 | $0.27 | $324 | 1,201 | SEC↗ |
| Oron Assaf | Chief Business Officer | A Award deriv | 2023-03-01 | 2023-03-03 | 50,000 | — | $0 | 50,000 | SEC↗ |
| Solomon Jonathan Eitan | Chief Executive Officer | A Award deriv | 2023-03-01 | 2023-03-03 | 410,000 | — | $0 | 410,000 | SEC↗ |
| Sullivan Lynne Marie | Director | A Award deriv | 2023-03-01 | 2023-03-03 | 41,000 | — | $0 | 41,000 | SEC↗ |
| Wolfson Marina | Chief Financial Officer | A Award deriv | 2023-03-01 | 2023-03-03 | 100,000 | — | $0 | 100,000 | SEC↗ |
| Bassan Merav | Chief Development Officer | A Award deriv | 2023-03-01 | 2023-03-03 | 100,000 | — | $0 | 100,000 | SEC↗ |
| Moses Alan Charles | Director | A Award deriv | 2023-03-01 | 2023-03-03 | 41,000 | — | $0 | 41,000 | SEC↗ |
| Greig Russell | Director | A Award deriv | 2023-03-01 | 2023-03-03 | 82,000 | — | $0 | 82,000 | SEC↗ |
| OrbiMed Israel GP Ltd. | 10% Owner | P Buy deriv | 2023-02-27 | 2023-03-17 | 1,789,959 | — | $0 | 1,789,959 | SEC↗ |
| OrbiMed Israel GP Ltd. | 10% Owner | P Buy | 2023-02-27 | 2023-03-17 | 348,000 | $0.25 | $87.0K | 3,161,489 | SEC↗ |
| Ugwumba Chidozie | Other | S Sale | 2022-11-04 | 2022-11-14 | 1,501 | $0.38 | $570 | 2,997,025 | SEC↗ |
| Ugwumba Chidozie | Other | S Sale | 2022-11-03 | 2022-11-14 | 2,000 | $0.37 | $740 | 2,998,526 | SEC↗ |
| Ugwumba Chidozie | Other | S Sale | 2022-11-02 | 2022-11-14 | 2,416 | $0.36 | $870 | 3,000,526 | SEC↗ |
| Ugwumba Chidozie | Other | S Sale | 2022-11-01 | 2022-11-14 | 1,300 | $0.36 | $468 | 3,002,942 | SEC↗ |
| Ugwumba Chidozie | Other | S Sale | 2022-10-31 | 2022-11-14 | 3,300 | $0.37 | $1.2K | 3,004,242 | SEC↗ |
| Ugwumba Chidozie | Other | S Sale | 2022-10-28 | 2022-11-14 | 1,526 | $0.36 | $549 | 3,007,542 | SEC↗ |
| Ugwumba Chidozie | Other | S Sale | 2022-10-27 | 2022-11-14 | 1,505 | $0.36 | $542 | 3,009,068 | SEC↗ |
| Ugwumba Chidozie | Other | S Sale | 2022-10-26 | 2022-11-14 | 12,500 | $0.35 | $4.4K | 3,010,573 | SEC↗ |
| Ugwumba Chidozie | Other | S Sale | 2022-10-25 | 2022-11-14 | 3,072 | $0.37 | $1.1K | 3,023,073 | SEC↗ |
| Ugwumba Chidozie | Other | S Sale | 2022-10-24 | 2022-11-14 | 5,900 | $0.35 | $2.1K | 3,026,145 | SEC↗ |
| Ugwumba Chidozie | Other | S Sale | 2022-10-21 | 2022-11-14 | 5,400 | $0.37 | $2.0K | 3,032,045 | SEC↗ |
| Ugwumba Chidozie | Other | S Sale | 2022-10-20 | 2022-11-14 | 6,636 | $0.37 | $2.5K | 3,037,445 | SEC↗ |
| Ugwumba Chidozie | Other | S Sale | 2022-10-19 | 2022-11-14 | 4,501 | $0.37 | $1.7K | 3,044,081 | SEC↗ |
| Ugwumba Chidozie | Other | S Sale | 2022-10-18 | 2022-11-14 | 15,300 | $0.35 | $5.4K | 3,048,582 | SEC↗ |
| Ugwumba Chidozie | Other | S Sale | 2022-10-17 | 2022-11-14 | 8,098 | $0.34 | $2.8K | 3,063,882 | SEC↗ |
| Ugwumba Chidozie | Other | S Sale | 2022-10-14 | 2022-11-14 | 3,420 | $0.33 | $1.1K | 3,071,980 | SEC↗ |
| Ugwumba Chidozie | Other | S Sale | 2022-10-13 | 2022-11-14 | 11,314 | $0.33 | $3.7K | 3,075,400 | SEC↗ |
| Ugwumba Chidozie | Other | S Sale | 2022-10-12 | 2022-11-14 | 9,700 | $0.33 | $3.2K | 3,086,714 | SEC↗ |
| Ugwumba Chidozie | Other | S Sale | 2022-10-11 | 2022-11-14 | 5,988 | $0.33 | $2.0K | 3,096,414 | SEC↗ |
| Ugwumba Chidozie | Other | S Sale | 2022-10-10 | 2022-11-14 | 10,043 | $0.33 | $3.3K | 3,102,402 | SEC↗ |
| Ugwumba Chidozie | Other | S Sale | 2022-10-07 | 2022-11-14 | 24,708 | $0.36 | $8.9K | 3,112,445 | SEC↗ |
| Ugwumba Chidozie | Other | S Sale | 2022-10-06 | 2022-11-14 | 25,098 | $0.44 | $11.0K | 3,137,153 | SEC↗ |
| Ugwumba Chidozie | Other | S Sale | 2022-10-05 | 2022-11-14 | 46,785 | $0.44 | $20.6K | 3,162,251 | SEC↗ |
| Ugwumba Chidozie | Other | S Sale | 2022-10-04 | 2022-11-14 | 19,200 | $0.34 | $6.5K | 3,209,036 | SEC↗ |
| Ugwumba Chidozie | Other | S Sale | 2022-10-03 | 2022-11-14 | 15,022 | $0.33 | $5.0K | 3,228,236 | SEC↗ |
| Ugwumba Chidozie | Other | S Sale | 2022-09-30 | 2022-11-14 | 8,662 | $0.36 | $3.1K | 3,243,258 | SEC↗ |
| Ugwumba Chidozie | Other | S Sale | 2022-09-29 | 2022-11-14 | 3,300 | $0.35 | $1.2K | 3,251,920 | SEC↗ |
| Ugwumba Chidozie | Other | S Sale | 2022-09-28 | 2022-11-14 | 15,649 | $0.33 | $5.2K | 3,255,220 | SEC↗ |
| Ugwumba Chidozie | Other | S Sale | 2022-09-27 | 2022-11-14 | 4,866 | $0.33 | $1.6K | 3,270,869 | SEC↗ |
| Ugwumba Chidozie | Other | S Sale | 2022-09-26 | 2022-11-14 | 17,528 | $0.36 | $6.3K | 3,275,735 | SEC↗ |
| Ugwumba Chidozie | Other | S Sale | 2022-09-23 | 2022-11-14 | 5,306 | $0.37 | $2.0K | 3,293,263 | SEC↗ |
| Ugwumba Chidozie | Other | S Sale | 2022-09-22 | 2022-11-14 | 17,388 | $0.41 | $7.1K | 3,298,569 | SEC↗ |
| Ugwumba Chidozie | Other | S Sale | 2022-09-21 | 2022-11-14 | 5,574 | $0.43 | $2.4K | 3,315,957 | SEC↗ |
| Ugwumba Chidozie | Other | S Sale | 2022-09-20 | 2022-11-14 | 10,626 | $0.45 | $4.8K | 3,321,531 | SEC↗ |
| Ugwumba Chidozie | Other | S Sale | 2022-09-19 | 2022-11-14 | 13,870 | $0.49 | $6.8K | 3,332,157 | SEC↗ |
| Ugwumba Chidozie | Other | S Sale | 2022-09-16 | 2022-11-14 | 3,200 | $0.51 | $1.6K | 3,346,027 | SEC↗ |
| Ugwumba Chidozie | Other | S Sale | 2022-09-15 | 2022-11-14 | 3,900 | $0.53 | $2.1K | 3,349,227 | SEC↗ |
| Ugwumba Chidozie | Other | S Sale | 2022-09-14 | 2022-11-14 | 2,301 | $0.52 | $1.2K | 3,353,127 | SEC↗ |
| Ugwumba Chidozie | Other | S Sale | 2022-09-13 | 2022-11-14 | 2,201 | $0.53 | $1.2K | 3,335,428 | SEC↗ |
| Ugwumba Chidozie | Other | S Sale | 2022-09-12 | 2022-11-14 | 1,700 | $0.54 | $918 | 3,357,629 | SEC↗ |
| Ugwumba Chidozie | Other | S Sale | 2022-09-09 | 2022-11-14 | 13,219 | $0.52 | $6.9K | 3,359,329 | SEC↗ |
| Ugwumba Chidozie | Other | S Sale | 2022-09-08 | 2022-11-14 | 4,592 | $0.52 | $2.4K | 3,372,548 | SEC↗ |
| Ugwumba Chidozie | Other | S Sale | 2022-09-07 | 2022-11-14 | 8,846 | $0.53 | $4.7K | 3,377,140 | SEC↗ |
| Ugwumba Chidozie | Other | S Sale | 2022-09-06 | 2022-11-14 | 6,403 | $0.55 | $3.5K | 3,385,986 | SEC↗ |
| Ugwumba Chidozie | Other | S Sale | 2022-09-02 | 2022-11-14 | 2,001 | $0.55 | $1.1K | 3,392,389 | SEC↗ |
| Ugwumba Chidozie | Other | S Sale | 2022-09-01 | 2022-11-14 | 8,297 | $0.55 | $4.6K | 3,394,390 | SEC↗ |
| Ugwumba Chidozie | Other | S Sale | 2022-08-31 | 2022-11-14 | 4,540 | $0.55 | $2.5K | 3,402,687 | SEC↗ |
| Ugwumba Chidozie | Other | S Sale | 2022-08-30 | 2022-11-14 | 13,487 | $0.57 | $7.7K | 3,407,227 | SEC↗ |
| Ugwumba Chidozie | Other | S Sale | 2022-08-29 | 2022-11-14 | 11,533 | $0.57 | $6.6K | 3,420,714 | SEC↗ |
| Ugwumba Chidozie | Other | S Sale | 2022-08-26 | 2022-11-14 | 60,628 | $0.62 | $37.6K | 3,432,247 | SEC↗ |
| Ugwumba Chidozie | Other | S Sale | 2022-08-25 | 2022-11-14 | 26,945 | $0.72 | $19.4K | 3,492,875 | SEC↗ |
| Ugwumba Chidozie | Other | S Sale | 2022-08-24 | 2022-11-14 | 8,665 | $0.65 | $5.6K | 3,519,820 | SEC↗ |
| Ugwumba Chidozie | Other | S Sale | 2022-08-23 | 2022-11-14 | 5,900 | $0.64 | $3.8K | 3,528,485 | SEC↗ |
| Ugwumba Chidozie | Other | S Sale | 2022-08-22 | 2022-11-14 | 5,000 | $0.66 | $3.3K | 3,534,385 | SEC↗ |
| Bassan Merav | Chief Development Officer | A Award deriv | 2022-08-22 | 2022-08-24 | 75,000 | — | $0 | 75,000 | SEC↗ |
| Solomon Jonathan Eitan | Chief Executive Officer | A Award deriv | 2022-08-22 | 2022-08-24 | 100,000 | — | $0 | 100,000 | SEC↗ |
| Wolfson Marina | Chief Financial Officer | A Award deriv | 2022-08-22 | 2022-08-24 | 75,000 | — | $0 | 75,000 | SEC↗ |
| Ugwumba Chidozie | Other | S Sale | 2022-08-19 | 2022-11-14 | 14,600 | $0.64 | $9.3K | 3,539,385 | SEC↗ |
| Ugwumba Chidozie | Other | S Sale | 2022-08-18 | 2022-11-14 | 7,764 | $0.68 | $5.3K | 3,553,985 | SEC↗ |
| Ugwumba Chidozie | Other | S Sale | 2022-08-17 | 2022-11-14 | 21,335 | $0.69 | $14.7K | 3,561,749 | SEC↗ |
| Ugwumba Chidozie | Other | S Sale | 2022-08-16 | 2022-11-14 | 8,563 | $0.73 | $6.3K | 3,583,084 | SEC↗ |
| Ugwumba Chidozie | Other | S Sale | 2022-08-15 | 2022-11-14 | 7,200 | $0.75 | $5.4K | 3,591,647 | SEC↗ |
| Ugwumba Chidozie | Other | S Sale | 2022-08-12 | 2022-11-14 | 11,406 | $0.73 | $8.3K | 3,598,847 | SEC↗ |
| Ugwumba Chidozie | Other | S Sale | 2022-08-11 | 2022-11-14 | 9,824 | $0.74 | $7.3K | 3,610,253 | SEC↗ |
| Ugwumba Chidozie | Other | S Sale | 2022-08-10 | 2022-11-14 | 17,769 | $0.74 | $13.1K | 3,620,077 | SEC↗ |
| Amusa Gbolahan | Director | A Award deriv | 2022-03-29 | 2022-03-31 | 20,500 | — | $0 | 20,500 | SEC↗ |
| GROSSMAN JONAS | Director | A Award deriv | 2022-03-29 | 2022-03-31 | 20,500 | — | $0 | 20,500 | SEC↗ |
| Solomon Jonathan Eitan | Chief Executive Officer | A Award deriv | 2022-03-29 | 2022-03-31 | 205,000 | — | $0 | 205,000 | SEC↗ |
| Sullivan Lynne Marie | Director | A Award deriv | 2022-03-29 | 2022-03-31 | 20,500 | — | $0 | 20,500 | SEC↗ |
| Wolfson Marina | SVP of Finance & Operations | A Award deriv | 2022-03-29 | 2022-03-31 | 50,000 | — | $0 | 50,000 | SEC↗ |
| Bassan Merav | Chief Development Officer | A Award deriv | 2022-03-29 | 2022-03-31 | 100,000 | — | $0 | 100,000 | SEC↗ |
| Moses Alan Charles | Director | A Award deriv | 2022-03-29 | 2022-03-31 | 20,500 | — | $0 | 20,500 | SEC↗ |
| Greig Russell | Director | A Award deriv | 2022-03-29 | 2022-03-31 | 41,000 | — | $0 | 41,000 | SEC↗ |
| Walton Thomas Layton | 10% Owner | J Other deriv | 2021-12-31 | 2022-02-14 | 1,875,000 | — | $0 | 0 | SEC↗ |
| Walton Thomas Layton | 10% Owner | J Other | 2021-12-31 | 2022-02-14 | 3,637,846 | — | $0 | 0 | SEC↗ |
| Moses Alan Charles | Director | P Buy deriv | 2021-07-28 | 2021-07-30 | 3,750 | — | $0 | 3,750 | SEC↗ |
| SEKHRI PAUL J | Director | P Buy deriv | 2021-07-28 | 2021-07-30 | 9,375 | — | $0 | 9,375 | SEC↗ |
| Greig Russell | Director | P Buy deriv | 2021-07-28 | 2021-07-30 | 2,813 | — | $0 | 2,813 | SEC↗ |
| Solomon Jonathan Eitan | Chief Executive Officer | P Buy deriv | 2021-07-28 | 2021-07-30 | 18,750 | — | $0 | 18,750 | SEC↗ |
| Sullivan Lynne Marie | Director | P Buy deriv | 2021-07-28 | 2021-07-30 | 9,375 | — | $0 | 9,375 | SEC↗ |
| Wolfson Marina | SVP of Finance & Operations | P Buy deriv | 2021-07-28 | 2021-07-30 | 2,813 | — | $0 | 2,813 | SEC↗ |
| OrbiMed Israel BioFund GP Limi | 10% Owner | P Buy deriv | 2021-07-28 | 2021-07-30 | 375,000 | — | $0 | 375,000 | SEC↗ |
| Moses Alan Charles | Director | P Buy | 2021-07-28 | 2021-07-30 | 5,000 | $4.00 | $20.0K | 5,000 | SEC↗ |
| SEKHRI PAUL J | Director | P Buy | 2021-07-28 | 2021-07-30 | 12,500 | $4.00 | $50.0K | 12,500 | SEC↗ |
| Greig Russell | Director | P Buy | 2021-07-28 | 2021-07-30 | 3,750 | $4.00 | $15.0K | 3,750 | SEC↗ |
| Solomon Jonathan Eitan | Chief Executive Officer | P Buy | 2021-07-28 | 2021-07-30 | 25,000 | $4.00 | $100.0K | 25,000 | SEC↗ |
| Sullivan Lynne Marie | Director | P Buy | 2021-07-28 | 2021-07-30 | 12,500 | $4.00 | $50.0K | 12,500 | SEC↗ |
| Wolfson Marina | SVP of Finance & Operations | P Buy | 2021-07-28 | 2021-07-30 | 3,750 | $4.00 | $15.0K | 3,750 | SEC↗ |
| OrbiMed Israel BioFund GP Limi | 10% Owner | P Buy | 2021-07-28 | 2021-07-30 | 500,000 | — | $0 | 2,813,489 | SEC↗ |
| Amusa Gbolahan | Director | P Buy deriv | 2021-07-26 | 2021-07-28 | 18,750 | — | $0 | 18,750 | SEC↗ |
| GROSSMAN JONAS | Director | P Buy deriv | 2021-07-26 | 2021-07-28 | 28,125 | — | $0 | 28,125 | SEC↗ |
| Amusa Gbolahan | Director | P Buy | 2021-07-26 | 2021-07-28 | 25,000 | — | $0 | 262,871 | SEC↗ |
| GROSSMAN JONAS | Director | P Buy | 2021-07-26 | 2021-07-28 | 37,500 | — | $0 | 372,217 | SEC↗ |
| GROSSMAN JONAS | Director | P Buy | 2021-07-26 | 2021-08-17 | 37,500 | — | $0 | 372,717 | SEC↗ |
| Amusa Gbolahan | Director | A Award deriv | 2021-03-30 | 2021-04-01 | 15,200 | — | $0 | 15,200 | SEC↗ |
| GROSSMAN JONAS | Director | A Award deriv | 2021-03-30 | 2021-04-01 | 15,200 | — | $0 | 15,200 | SEC↗ |
| Solomon Jonathan Eitan | Chief Executive Officer | A Award deriv | 2021-03-30 | 2021-04-01 | 152,000 | — | $0 | 152,000 | SEC↗ |
| Sullivan Lynne Marie | Director | A Award deriv | 2021-03-30 | 2021-04-01 | 15,200 | — | $0 | 15,200 | SEC↗ |
| Wolfson Marina | SVP of Finance & Operations | A Award deriv | 2021-03-30 | 2021-04-01 | 33,250 | — | $0 | 33,250 | SEC↗ |
| Bassan Merav | Chief Development Officer | A Award deriv | 2021-03-30 | 2021-04-01 | 47,500 | — | $0 | 47,500 | SEC↗ |
| Moses Alan Charles | Director | A Award deriv | 2021-03-30 | 2021-04-01 | 15,200 | — | $0 | 15,200 | SEC↗ |
| Oron Assaf | Chief Business Officer | A Award deriv | 2021-03-30 | 2021-04-01 | 33,250 | — | $0 | 33,250 | SEC↗ |
| SEKHRI PAUL J | Director | A Award deriv | 2021-03-30 | 2021-04-01 | 15,200 | — | $0 | 15,200 | SEC↗ |
| Greig Russell | Director | A Award deriv | 2021-03-30 | 2021-04-01 | 30,400 | — | $0 | 30,400 | SEC↗ |
| Puttagunta Sailaja | Chief Medical Officer | A Award deriv | 2021-03-30 | 2021-04-01 | 71,250 | — | $0 | 71,250 | SEC↗ |
| Moses Alan Charles | Director | A Award deriv | 2020-10-02 | 2020-10-05 | 16,000 | — | $0 | 16,000 | SEC↗ |
| SEKHRI PAUL J | Director | A Award deriv | 2020-10-02 | 2020-10-05 | 16,000 | — | $0 | 16,000 | SEC↗ |
| GROSSMAN JONAS | Director | P Buy deriv | 2020-07-26 | 2021-08-17 | 28,125 | — | $0 | 28,125 | SEC↗ |
| GROSSMAN JONAS | Director | J Other deriv | 2020-07-13 | 2020-07-22 | 666,310 | — | $0 | 716,439 | SEC↗ |
| Mountain Wood LLC | 10% Owner | J Other deriv | 2020-07-13 | 2020-07-22 | 631,786 | — | $0 | 631,786 | SEC↗ |
| Mountain Wood LLC | 10% Owner | J Other deriv | 2020-07-13 | 2020-07-22 | 2,900,000 | — | $0 | 0 | SEC↗ |
| Amusa Gbolahan | Director | J Other deriv | 2020-07-13 | 2020-07-27 | 276,190 | — | $0 | 276,190 | SEC↗ |
| GROSSMAN JONAS | Director | J Other | 2020-07-13 | 2020-07-22 | 229,545 | — | $0 | 335,217 | SEC↗ |
| Mountain Wood LLC | 10% Owner | J Other | 2020-07-13 | 2020-07-22 | 217,652 | — | $0 | 260,771 | SEC↗ |
| Mountain Wood LLC | 10% Owner | J Other | 2020-07-13 | 2020-07-22 | 999,058 | — | $0 | 0 | SEC↗ |
| Amusa Gbolahan | Director | J Other | 2020-07-13 | 2020-07-27 | 95,148 | — | $0 | 237,871 | SEC↗ |
| GROSSMAN JONAS | Director | J Other | 2020-06-18 | 2020-07-22 | 45,275 | — | $0 | 0 | SEC↗ |
| Amusa Gbolahan | Director | J Other | 2020-06-10 | 2020-06-12 | 142,723 | — | $0 | 142,723 | SEC↗ |
| GROSSMAN JONAS | Director | J Other | 2020-06-10 | 2020-06-12 | 99,172 | — | $0 | 105,672 | SEC↗ |
| GROSSMAN JONAS | Director | J Other | 2020-06-10 | 2020-06-12 | 42,275 | — | $0 | 45,275 | SEC↗ |
| GROSSMAN JONAS | Director | J Other | 2020-06-10 | 2020-06-12 | 1,707,500 | — | $0 | 0 | SEC↗ |
| Mountain Wood LLC | 10% Owner | J Other | 2020-06-10 | 2020-06-12 | 999,058 | — | $0 | 999,058 | SEC↗ |
| Mountain Wood LLC | 10% Owner | J Other | 2020-06-10 | 2020-06-12 | 43,119 | — | $0 | 43,119 | SEC↗ |
| Sullivan Lynne Marie | Director | A Award deriv | 2020-03-25 | 2020-03-27 | 16,000 | — | $0 | 16,000 | SEC↗ |
| Breski Yaron | Director | A Award deriv | 2020-03-25 | 2020-03-27 | 16,000 | — | $0 | 16,000 | SEC↗ |
| Wolfson Marina | Principal Financial Officer | A Award deriv | 2020-03-25 | 2020-03-27 | 36,000 | — | $0 | 36,000 | SEC↗ |
| Puttagunta Sailaja | Chief Medical Officer | A Award deriv | 2020-03-25 | 2020-03-27 | 67,500 | — | $0 | 67,500 | SEC↗ |
| Greig Russell | Director | A Award deriv | 2020-03-25 | 2020-03-27 | 32,000 | — | $0 | 32,000 | SEC↗ |
| Solomon Jonathan Eitan | Chief Executive Officer | A Award deriv | 2020-03-25 | 2020-03-27 | 144,000 | — | $0 | 144,000 | SEC↗ |
| GROSSMAN JONAS | Director | A Award deriv | 2020-03-25 | 2020-03-27 | 16,000 | — | $0 | 16,000 | SEC↗ |
| Chimovits Erez | Director, 10% Owner | A Award deriv | 2020-03-25 | 2020-03-27 | 16,000 | — | $0 | 16,000 | SEC↗ |
| Amusa Gbolahan | Director | A Award deriv | 2020-03-25 | 2020-03-27 | 16,000 | — | $0 | 16,000 | SEC↗ |
| Oron Assaf | Chief Business Officer | A Award deriv | 2020-03-25 | 2020-03-27 | 31,500 | — | $0 | 31,500 | SEC↗ |
| GROSSMAN JONAS | Director, 10% Owner | J Other deriv | 2019-12-20 | 2019-12-30 | 2,900,000 | — | $0 | 0 | SEC↗ |
| Chimovits Erez | Director, 10% Owner | P Buy | 2019-12-19 | 2019-12-20 | 3,500 | $8.90 | $31.1K | 2,313,489 | SEC↗ |
| OrbiMed Israel GP Ltd. | Director, 10% Owner | P Buy | 2019-12-19 | 2019-12-20 | 3,500 | $8.90 | $31.1K | 2,313,489 | SEC↗ |
| Chimovits Erez | Director, 10% Owner | P Buy | 2019-12-18 | 2019-12-20 | 500 | $8.93 | $4.5K | 2,309,989 | SEC↗ |
| OrbiMed Israel GP Ltd. | Director, 10% Owner | P Buy | 2019-12-18 | 2019-12-20 | 500 | $8.93 | $4.5K | 2,309,989 | SEC↗ |
| OrbiMed Israel BioFund GP Limi | Director, 10% Owner | P Buy | 2019-12-11 | 2019-12-12 | 5,400 | $8.92 | $48.2K | 2,309,489 | SEC↗ |
| Chimovits Erez | Director, 10% Owner | P Buy | 2019-12-11 | 2019-12-12 | 5,400 | $8.92 | $48.2K | 2,309,489 | SEC↗ |
| OrbiMed Israel BioFund GP Limi | Director, 10% Owner | P Buy | 2019-12-10 | 2019-12-12 | 3,400 | $8.75 | $29.8K | 2,304,089 | SEC↗ |
| Chimovits Erez | Director, 10% Owner | P Buy | 2019-12-10 | 2019-12-12 | 3,400 | $8.75 | $29.8K | 2,304,089 | SEC↗ |
| Chimovits Erez | Director, 10% Owner | P Buy | 2019-12-09 | 2019-12-09 | 6,000 | $8.68 | $52.1K | 2,300,689 | SEC↗ |
| OrbiMed Israel GP Ltd. | Director, 10% Owner | P Buy | 2019-12-09 | 2019-12-09 | 6,000 | $8.68 | $52.1K | 2,300,689 | SEC↗ |
| Chimovits Erez | Director, 10% Owner | P Buy | 2019-12-06 | 2019-12-09 | 800 | $8.00 | $6.4K | 2,294,689 | SEC↗ |
| OrbiMed Israel GP Ltd. | Director, 10% Owner | P Buy | 2019-12-06 | 2019-12-09 | 800 | $8.00 | $6.4K | 2,294,689 | SEC↗ |
| Chimovits Erez | Director, 10% Owner | P Buy | 2019-12-05 | 2019-12-09 | 3,400 | $7.99 | $27.2K | 2,293,889 | SEC↗ |
| OrbiMed Israel GP Ltd. | Director, 10% Owner | P Buy | 2019-12-05 | 2019-12-09 | 3,400 | $7.99 | $27.2K | 2,293,889 | SEC↗ |
| GROSSMAN JONAS | Director, 10% Owner | P Buy | 2019-11-20 | 2019-11-20 | 1,400 | $8.00 | $11.2K | 6,500 | SEC↗ |
| GROSSMAN JONAS | Director, 10% Owner | P Buy | 2019-11-19 | 2019-11-20 | 4,100 | $7.57 | $31.0K | 5,100 | SEC↗ |
| GROSSMAN JONAS | Director, 10% Owner | P Buy deriv | 2019-11-18 | 2019-11-20 | 50,129 | $0.60 | $30.1K | 50,129 | SEC↗ |
| GROSSMAN JONAS | Director, 10% Owner | P Buy | 2019-11-18 | 2019-11-20 | 1,000 | $6.99 | $7.0K | 1,000 | SEC↗ |